From left: Henry Sun, president and CEO of Tasly Pharmaceuticals; Steven D. Caras, vice-president of Arbor Pharmaceuticals; Brain K Adams, vice-president of Arbor Pharmaceuticals; Ed Schutter, president and CEO of Arbor Pharmaceuticals; Naifeng Wu, president of Tasly Holding Group; Thom Rowland, vice-president of Arbor Pharmaceuticals; and Kaijing Yan, executive chairman of Tasly Holding Group, at the Tasly-Arbor signing ceremony for a US clinical co-development and commercialization agreement, in Rockville, MD on Sept 14. Provided to China Daily
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.